0 118

Cited 0 times in

Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study

Authors
 M-J. Ahn  ;  B.C. Cho  ;  Y.K. Pang  ;  P.J. Voon  ;  S-W. Kim  ;  J. De Castro Carpeno  ;  M. Tiseo  ;  J. Li  ;  L. Servidio  ;  S. Sadow  ;  A. Markovets  ;  K.H. Tang  ;  Z. Piotrowska 
Citation
 ANNALS OF ONCOLOGY, Vol.33(Supplement 9) : S1563-S1564, 2022-11 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2022-11
Full Text
https://www.sciencedirect.com/science/article/pii/S0923753422045458
DOI
10.1016/j.annonc.2022.10.354
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194789
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links